Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > I agree with Kwdelux 100%....Pharma is not buying, but could
View:
Post by canadafan on Aug 04, 2022 8:25pm

I agree with Kwdelux 100%....Pharma is not buying, but could

I agree with KW delux analysis 100%.
Big pharma is not in the business of stock manipulation.
If they decied to "buy" onc it will be an an all-in offer.
For them to Quietly accumulate? not their bag.
A board decisiion would be made and negotiations would start.

That -said, not is not beyond institutions to aquire on the wisper of news etc.
All..good data and indicatons,
The 3 ou of 3 patents responding with a 50% shrinkage is awsome!
Yes only 3, but they have quickly advanced to full enrolment.
All open lable & all real time.
Roche will know sson enoghif they want to fund a phase 3 partnership.
Comment by Lesalpes29 on Aug 04, 2022 10:07pm
Big pharma is not in the business of stock manipulation. Why they wouldn't do it!
Comment by Lesalpes29 on Aug 05, 2022 6:28am
Probably that I am wrong and it's not important. We see that often in mining... a big boy taking position in an exploration play after good results. Or a big drop of the SP before a buyout... don't know who could be behind? In TRIL case, if I remember well, we have seen a SP drop just before the buyout. Coincidence probably.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities